Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
about
Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challengesCombination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cellsPharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapyFunctional DNA repair signature of cancer cell lines exposed to a set of cytotoxic anticancer drugs using a multiplexed enzymatic repair assay on biochipChemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer CellsGlobal gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancerAnalysis of individual molecular events of DNA damage response by flow- and image-assisted cytometrySensitization strategies in lung cancerThe DNA damage response: Balancing the scale between cancer and ageing.Differential proteomics in the search for biomarkers of radiotherapy resistance.Oxidative stress in apoptosis and cancer: an update.Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence.Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT.Positioning effects of KillerRed inside of cells correlate with DNA strand breaks after activation with visible light.NRAGE is involved in homologous recombination repair to resist the DNA-damaging chemotherapy and composes a ternary complex with RNF8-BARD1 to promote cell survival in squamous esophageal tumorigenesis.DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategiesMolecular mechanism of base pairing infidelity during DNA duplication upon one-electron oxidation.Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
P2860
Q26827820-98B535F8-40DD-4AA3-AC02-93B02FD2021DQ28395254-2C0F0956-DCCE-4389-A440-E36E32E49CA2Q28477147-1DC3AB3A-8E37-441D-B66A-3F775A2E85D9Q28484673-D429561D-EAAE-41DC-8EF1-8EAB35394A4DQ28816971-D1F83A05-4B33-4B12-912D-6CA7506D2B46Q28829385-A1B0B450-D4BB-4E6A-A6A4-A361DA42C9CDQ33948911-F74E0C48-B0EE-43C5-A7DA-6F8EA002CEECQ37407122-5AE1462F-256A-4553-A9EC-CC69313F2D3CQ37824549-D14A168F-3EDF-4491-A18B-085E620A7CD2Q37912208-D80CAECD-90AC-4B45-A874-CB085EAA324EQ38027434-DA2A3D61-F8FF-448F-B81B-D268C40A78DDQ38743262-F8EC3CE6-2968-4ACB-8E02-42ACAC303A58Q39300990-1F462252-584C-4744-951D-619C4CE781F2Q39492096-9BB13688-25D8-4E21-94FC-D7B2C961936CQ39600586-5CA52ACA-9762-4471-A09F-9C0556DBF3BEQ41870614-E0A8F80B-F511-4DA3-BB4F-EA6D97B14C91Q42150992-F4E6A69E-FCE1-4377-92F0-240A66A87AE4Q42733678-C16A7F34-6AB6-496A-88A3-3FD1036BB2A0Q47139818-7FA098CE-FE7D-4993-A739-8418972DF585
P2860
Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impaired DNA damage response-- ...... chemotherapy and radiotherapy.
@en
Impaired DNA damage response-- ...... chemotherapy and radiotherapy.
@nl
type
label
Impaired DNA damage response-- ...... chemotherapy and radiotherapy.
@en
Impaired DNA damage response-- ...... chemotherapy and radiotherapy.
@nl
prefLabel
Impaired DNA damage response-- ...... chemotherapy and radiotherapy.
@en
Impaired DNA damage response-- ...... chemotherapy and radiotherapy.
@nl
P2860
P50
P921
P1476
Impaired DNA damage response-- ...... chemotherapy and radiotherapy.
@en
P2860
P304
P356
10.1016/J.EJPHAR.2009.05.032
P407
P577
2009-10-18T00:00:00Z